Variant Perception

Where We Disagree With the Market

The market is debating Avation as a valuation question — 0.48× book is either a deep-value re-rating opportunity or a fair price for a sub-scale, B-rated lessor — but the binding constraint is structural and hidden: this stock cannot absorb institutional capital. Five-day execution capacity at 20% of average volume is roughly $16M, or 0.17% of market cap; the only meaningful marginal buyer in the tape today is the company itself. That single fact reframes the thesis. The realistic path to closing the NAV gap is not a re-rating cycle driven by FY2026 results; it is a takeout by a top-five lessor inside the next 24-36 months. Two further disagreements compound the picture: stated NAV is roughly half model-derived (the headline 0.45× P/B masks tangible economic book closer to 0.85×), and the activist exit that the tape is reading as defeat looks much more like a textbook value-realization harvest after the buyback rerated the stock from 79p to 165p.

Variant Perception Scorecard

The variant strength is moderate (62) rather than high because the thesis is more about reframing the trade than calling a directional surprise. Consensus clarity is the weakest input (58) — there is no functioning sell-side consensus to disagree with; coverage is a single analyst at 270p and a handful of stale third-party fair-value models. Evidence strength is the highest input (70): the liquidity, NAV-composition, and activist-rotation facts are concretely documented in filings, RNS history, and the trading tape. Eighteen months is the realistic window because the takeout case requires either an FY2026 cash-quality print clean enough to interest a strategic, the Citi advisory mandate (standing since FY23) producing a process, or a credit-improvement loop that lifts the stock without buy-side flow — none of which resolve in 90 days.

Consensus Map

The cleanest reading of the consensus is paradoxical: there is broad agreement on the math (NAV discount, buyback accretion, structural cost of debt, FY26 catalyst) and broad disagreement on the direction (bull $3.00 vs bear $1.10) — but no one in the public debate is questioning the scaffolding of the trade itself. Our disagreements live in that scaffolding.

The Disagreement Ledger

#1 — Liquidity is the binding constraint, not valuation

A consensus analyst would say: the FY26 print resolves the cash-quality dispute; if recurring CFO clears $80M, the multiple compresses toward Air Lease at 0.85× P/B. Our evidence disagrees because that thesis requires a marginal institutional buyer who, on the current register, does not exist. The activist has gone from 25% to 6%, no new 5%+ holder has emerged, the diluted share count has been deliberately shrunk by 14% in 18 months, and the company itself is the only consistent bid in a $16M-ADV name. If we are right, the market would have to concede that the persistent 0.45× discount is mostly a microstructure artifact — not a reflection of recurring earnings — and that the only realistic monetization path is a strategic bid from AerCap, Air Lease, BOC Aviation, or Avolon. The cleanest disconfirming signal is a major-holdings RNS showing a new institutional 5%+ holder — proof that real money can absorb the float at scale.

#2 — Stated NAV is half a model output

A consensus analyst would say: book value is $3.70/share, the stock is at 0.48×, that gap is the trade. Our evidence disagrees because $62M of asset-revaluation reserve runs through OCI (not the audited income statement), $92M of Level-3 purchase rights are marked via Black-Scholes (a $68.5M two-year P&L swing), and the much-cited $552M Cirium value of the 24 ATR purchase rights requires capex that the company structurally cannot fund — by their nature unmonetizable except through a partner JV that management floated and quietly dropped. Strip the soft equity and the right denominator is closer to $2.10/share tangible. If we are right, the market would have to concede that the bull-case 0.80× book → $3.00 target is overstated by roughly 35%, while the bear-case $1.10 floor is about right but for the wrong reason — multiple compression on a real book, not a re-rate failure. The cleanest disconfirming signal is a third-party transaction (JV, secondary sale, or option monetization) that crystallizes any portion of the $552M Cirium value and forces the market to honor it.

#3 — The activist exit is the trade working, not the trade failing

A consensus analyst would say: the activist sold, the price fell to a 52-week low, the smart money has voted with its feet. Our evidence disagrees because Rangeley/Raper bought a 19% block from forced-seller Oceanwood at 79p in November 2023, watched the stock more than double to a 165p FY25 high, accumulated to 25% during the run, and is now reducing into the company's own buyback. That is a textbook value-realization sequence, not capitulation. The activist mandate ("less of a discussion, more of a dictation") was always to extract value for all shareholders; that has happened. If we are right, the market is misreading capital rotation as defeat and is overlooking the fact that the residual alignment (founder Chatfield's 18.6% holding, five consecutive years of zero cash bonus, an aggressive buyback at half book) is unusually clean. The cleanest disconfirming signal is founder Chatfield trimming via Epsom Assets, or the activist falling below 3% with no replacement holder appearing — that would invert the read.

Evidence That Changes the Odds

How This Gets Resolved

The two signals that resolve the variant fastest are also the noisiest: the major-holdings RNS register (Variant 1 and 3) and the September 2026 cash-flow walk (Variants 1 and 2). The takeout-validation path — a Rule 2 disclosure under the Takeover Code — is the cleanest single-event resolution but the least controllable in timing.

What Would Make Us Wrong

The simplest way the variant view fails is the boring one: a clean FY2026 audit prints OCF before working capital at $85M+ with no second maintenance-reserve add-back, interest coverage walks through 1.5× as IFRS 9 accretion runs off, the buyback continues to remove float at half book, and a fresh institutional buyer crosses the 5% RNS disclosure threshold. In that world, the discount compresses on its own — no takeout needed, the activist exit looks like rational rotation rather than a structural read, the NAV anchor proves to be a fair denominator, and our liquidity-trap framing reduces to a sizing question rather than a thesis-defining constraint. Half of that case (FY26 print) is binary and decided in 150 days. We should be honest that on a probability basis, a clean print plus continued buyback discipline is roughly a coin flip, not a 30/70 outcome — and a coin-flip outcome that breaks against the variant kills the thesis quickly.

The variant on tangible book ($2.10/share, 0.85× P/B) is the most fragile of the three because it depends on stripping the Black-Scholes mark on purchase rights — and a credible JV or partial monetization at scale (a re-floated version of the H1 FY25 idea) would prove the option value is real, not paper. If a top-tier lessor or fund partner buys, say, 50% of the 24 purchase rights at half the Cirium value, that single transaction crystallizes ~$130M of equity in one disclosure and revalidates the bull-case anchor on stated NAV. Management has the ATR relationships and the legal framework already; the absence of a deal is information today but it is not destiny.

The activist-as-success variant assumes Rangeley/Raper rotated capital because the trade worked, not because they lost confidence in the residual upside. That read is consistent with the price history (entry 79p, exit at 130-160p over 24-30 months), but it is not the only consistent read. If the activist publicly disclosed that the discount cannot be closed without a structural change (delisting, sale of a divisional NAV slice, or a tender offer at premium pricing), our framing would have to retreat. So far they have not done so, but absence of a critical statement is also not proof of approval.

Finally, the liquidity-trap framing itself can be inverted by an exchange-segment upgrade. Avation sits in the LSE Equity Share (Transition) segment that exempts it from full UK Corporate Governance Code compliance; management floated an ESCC main-market listing transfer in H1 FY25 and let the idea go silent. A serious move into the main market would expand the eligible buyer base (some UK long-only funds cannot hold Transition-segment names), lift index inclusion eligibility, and could break the company-as-only-bid loop without requiring a strategic event.

The first thing to watch is the next major-holdings RNS notification — a new 5%+ institutional holder validates that real money can absorb the float and refutes the liquidity-trap variant; another tick down by Rangeley/Raper without a replacement confirms it.